A MISSENSE MUTATION (ASP(250)-]ASN) IN EXON-6 OF THE HUMAN LIPOPROTEIN-LIPASE GENE CAUSES CHYLOMICRONEMIA IN PATIENTS OF DIFFERENT ANCESTRIES

被引:41
作者
MA, YH
WILSON, BI
BIJVOET, S
HENDERSON, HE
CRAMB, E
ROEDERER, G
MURTHY, MRV
JULIEN, P
BAKKER, HD
KASTELEIN, JJP
BRUNZELL, JD
HAYDEN, MR
机构
[1] UNIV BRITISH COLUMBIA, DEPT MED GENET, F168 UNIV HOSP, 2211 WESBROOK MALL, VANCOUVER V6T 2B5, BC, CANADA
[2] UNIV CAPE TOWN, DEPT CHEM PATHOL, CAPE TOWN, SOUTH AFRICA
[3] UNIV AMSTERDAM, ACAD MED CTR, CTR HEMOSTASIS THROMBOSIS ATHEROSCLEROSIS & INFLAM, 1105 AZ AMSTERDAM, NETHERLANDS
[4] CLIN RES INST MONTREAL, MONTREAL H2W 1R7, QUEBEC, CANADA
[5] LAVAL UNIV, FAC MED, DEPT BIOCHEM, ST FOY, QUEBEC, CANADA
[6] UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA
[7] LAVAL UNIV, CHUL RES CTR, LIPID RES CTR, ST FOY, QUEBEC, CANADA
关键词
D O I
10.1016/0888-7543(92)90136-G
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We have previously reported two common lipoprotein lipase (LPL) gene mutations underlying LPL deficiency in the majority of 37 French Canadians (Monsalve et al., 1990. J. Clin. Invest. 86: 728-734; Ma et al., 1991. N. Engl. J. Med. 324: 1761-1766). By examining the 10 coding exons of the LPL gene in another French Canadian patient, we have identified a third missense mutation that is found in two of the three remaining patients for whom mutations are undefined. This is a G to A transition in exon 6 that results in a substitution of asparagine for aspartic acid at residue 250. Using in vitro site-directed mutagenesis, we have confirmed that this mutation causes a catalytically defective LPL protein. In addition, the Asp250→Asn mutation was also found on the same haplotype in an LPL-deficient patient of Dutch ancestry, suggesting a common origin. This mutation alters a TaqI restriction site in exon 6 and will allow for rapid screening in patients with LPL deficiency. © 1992.
引用
收藏
页码:649 / 653
页数:5
相关论文
共 16 条
[1]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[2]   DETECTION AND CHARACTERIZATION OF THE HETEROZYGOTE STATE FOR LIPOPROTEIN-LIPASE DEFICIENCY [J].
BABIRAK, SP ;
IVERIUS, PH ;
FUJIMOTO, WY ;
BRUNZELL, JD .
ARTERIOSCLEROSIS, 1989, 9 (03) :326-334
[3]  
Brunzell JD, 1989, METABOLIC BASIS INHE, P1165
[4]  
DATTA S, 1988, J BIOL CHEM, V263, P1107
[5]  
FAUSTINELLA F, 1991, J BIOL CHEM, V266, P14418
[6]   2 POLYMORPHISMS IN THE HUMAN LIPOPROTEIN-LIPASE (LPL) GENE [J].
FISHER, KL ;
FITZGERALD, GA ;
LAWN, RM .
NUCLEIC ACIDS RESEARCH, 1987, 15 (18) :7657-7657
[7]   HIND III-RFLP IN THE LIPOPROTEIN-LIPASE GENE, (LPL) [J].
FUNKE, H ;
KLUG, J ;
ASSMANN, G .
NUCLEIC ACIDS RESEARCH, 1987, 15 (21) :9102-9102
[8]  
GAGNE C, 1989, CAN MED ASSOC J, V140, P405
[9]   DIRECT DETECTION AND AUTOMATED SEQUENCING OF INDIVIDUAL ALLELES AFTER ELECTROPHORETIC STRAND SEPARATION - IDENTIFICATION OF A COMMON NONSENSE MUTATION IN EXON-9 OF THE HUMAN LIPOPROTEIN-LIPASE GENE [J].
HATA, A ;
ROBERTSON, M ;
EMI, M ;
LALOUEL, JM .
NUCLEIC ACIDS RESEARCH, 1990, 18 (18) :5407-5411
[10]  
Hayden M.R., 1991, CURRENT OPINION LIPI, V2, P104